David Mountcastle - 07 Jul 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas Bartrum, as attorney-in fact
Issuer symbol
PRVA
Transactions as of
07 Jul 2022
Transactions value $
-$34,218
Form type
4
Filing time
08 Jul 2022, 18:28:36 UTC
Previous filing
07 Jul 2022
Next filing
19 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock Options Exercise $4.98K +2.49K +2.73% $2.00* 93.9K 07 Jul 2022 Direct
transaction PRVA Common Stock Sale -$39.2K -1.21K -1.29% $32.35 92.7K 07 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -2.49K -13.95% $0.00 15.4K 07 Jul 2022 Common Stock 2.49K $2.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 8,930 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022 and 2,493 of the stock options will vest December 4, 2022.